参考文献/References:
[1] Zhou M,Wang H,Zeng X,et al.Mortality,morbidity,and risk factors in China and its provinces,1990—2017:a systematic analysis for the global burden of disease study 2017[J].Lancet,2019,394(10204):1145-1158.DOI:10.1016/S0140-6736(19)30427-1.
[2] Sánchez-García A,Rodríguez-Gutiérrez R,Mancillas-Adame L,et al.Diagnostic Accuracy of the Triglyceride and Glucose Index for Insulin Resistance:a Systematic Review[J].Int J Endocrinol,2020,2020:4678526.DOI:10.1155/2020/4678526.
[3] Wallace TM,Levy JC,Matthews DR.Use and abuse of HOMA modeling[J].Diabetes Care,2004,27(6):1487-1495.DOI:10.2337/diacare.27.6.1487.
[4] Simental-Mendía LE,Rodríguez-Morán M,Guerrero-Romero F.The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects[J].Metab Syndr Relat Disord,2008,6(4):299-304.DOI:10.1089/met.2008.0034.
[5] Won KB,Kim YS,Lee BK,et al.The relationship of insulin resistance estimated by triglyceride glucose index and coronary plaque characteristics[J].Medicine(Baltimore),2018,97(21):e10726.DOI:10.1097/MD.0000000000010726.
[6] Wang L,Cong HL,Zhang JX,et al.Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome[J].Cardiovasc Diabetol,2020,19(1):80.DOI:10.1186/s12933-020-01054-z.
[7] Luo E,Wang D,Yan G,et al.High triglyceride-glucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention[J].Cardiovasc Diabetol,2019,18(1):150.DOI:10.1186/s12933-019-0957-3.
[8] Won KB,Park EJ,Han D,et al.Triglyceride glucose index is an independent predictor for the progression of coronary artery calcification in the absence of heavy coronary artery calcification at baseline[J].Cardiovasc Diabetol,2020,19(1):34.DOI:10.1186/s12933-020-01008-5.
[9] Kim MK,Ahn CW,Kang S,et al.Relationship between the triglyceride glucose index and coronary artery calcification in Korean adults[J].Cardiovasc Diabetol,2017,16(1):108.DOI:10.1186/s12933-017-0589-4.
[10] Lee SB,Ahn CW,Lee BK,et al.Association between triglyceride glucose index and arterial stiffness in Korean adults[J].Cardiovasc Diabetol,2018,17(1):41.DOI:10.1186/s12933-018-0692-1.
[11] Li M,Zhan A,Huang X,et al.Positive association between triglyceride glucose index and arterial stiffness in hypertensive patients:the China H-type Hypertension registry study[J].Cardiovasc Diabetol,2020,19(1):139.DOI:10.1186/s12933-020-01124-2.
[12] da Silva A,Caldas APS,Rocha DMUP,et al.Triglyceride-glucose index predicts independently type 2 diabetes mellitus risk:a systematic review and meta-analysis of cohort studies[J].Prim Care Diabetes,2020,14(6):584-593.DOI:10.1016/j.pcd.2020.09.001.
[13] Babic N,Valjevac A,Zaciragic A,et al.The Triglyceride/HDL ratio and Triglyceride Glucose Index as predictors of glycemic control in patients with diabetes mellitus type 2[J].Med Arch,2019,73(3):163-168.DOI:10.5455/medarh.2019.73.163-168.
[14] Thai PV,Tien HA,Van Minh H,et al.Triglyceride glucose index for the detection of asymptomatic coronary artery stenosis in patients with type 2 diabetes[J].Cardiovasc Diabetol,2020,19(1):137.DOI:10.1186/s12933-020-01108-2.
[15] Chiu H,Tsai HJ,Huang JC,et al.Associations between Triglyceride-Glucose Index and Micro- and Macro-angiopathies in Type 2 Diabetes Mellitus[J].Nutrients,2020,12(2):328.DOI:10.3390/nu12020328.
[16] Watt MJ,Miotto PM,De Nardo W,et al.The liver as an endocrine Organ-Linking NAFLD and insulin resistance[J].Endocr Rev,2019,40:1367-1393.DOI:10.1210/er.2019-00034.
[17] Zhang S,Du T,Zhang J,et al.The triglyceride and glucose index(TyG)is an effective biomarker to identify nonalcoholic fatty liver disease[J].Lipids Health Dis,2017,16(1):15.DOI:10.1186/s12944-017-0409-6.
[18] Guo W,Lu J,Qin P,et al.The triglyceride-glucose index is associated with the severity of hepatic steatosis and the presence of liver fibrosis in non-alcoholic fatty liver disease:a cross-sectional study in Chinese adults[J].Lipids Health Dis,2020,19(1):218.DOI:10.1186/s12944-020-01393-6.
[19] Li R,Li Q,Cui M,et al.Clinical surrogate markers for predicting metabolic syndrome in middle-aged and elderly Chinese[J].J Diabetes Investig,2018,9(2):411-418.DOI:10.1111/jdi.12708.
[20] Yu X,Wang L,Zhang W,et al.Fasting triglycerides and glucose index is more suitable for the identification of metabolically unhealthy individuals in the Chinese adult population:a nationwide study[J].J Diabetes Investig,2019,10(4):1050-1058.DOI:10.1111/jdi.12975.
[21] Liu PJ,Lou HP,Zhu YN.Screening for metabolic syndrome using an integrated continuous index consisting of waist circumference and triglyceride:a preliminary cross-sectional study[J].Diabetes Metab Syndr Obes,2020,13:2899-2907.DOI:10.2147/DMSO.S259770.
[22] Ren H,Yang Y,Wang F,et al.Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19[J].Cardiovasc Diabetol,2020,11,19(1):58.DOI:10.1186/s12933-020-01035-2.
[23] Fritz J,Bjørge T,Nagel G,et al.The triglyceride-glucose index as a measure of insulin resistance and risk of obesity-related cancers[J].Int J Epidemiol,2020,49(1):193-204.DOI:10.1093/ije/dyz053.
相似文献/References:
[1]编辑部.网上快讯[J].国际内分泌代谢杂志,2007,(04):238.
[2]张晓燕,陈莉明.儿童非酒精性脂肪性肝病研究进展[J].国际内分泌代谢杂志,2007,(04):289.
[3]李娜娜 任寿安.慢性间歇低氧对大鼠肝细胞IRS-2、FoxO1表达的影响[J].国际内分泌代谢杂志,2015,(01):1.[doi:10.3760/cma.j.issn.1673-4157.2015.01.001]
Li Nana,Ren Shouan.Effects of chronic intermittent hypoxia on IRS-2 and FoxO1 expression in rat heptocytes[J].International Journal of Endocrinology and Metabolism,2015,(03):1.[doi:10.3760/cma.j.issn.1673-4157.2015.01.001]
[4]任国梅,任寿安.间歇低氧对大鼠肝脏GSK-3及mTOR表达的影响[J].国际内分泌代谢杂志,2015,(02):77.[doi:10.3760/cma.j.issn.1673-4157.2015.02.002]
Ren Guomei,Ren Shouan..Effects of intermittent hypoxia on the expression of GSK-3 and mTOR in rat liver[J].International Journal of Endocrinology and Metabolism,2015,(03):77.[doi:10.3760/cma.j.issn.1673-4157.2015.02.002]
[5]刘美娟,朱惠娟,龚凤英.Glypican-，4与肥胖及胰岛素抵抗[J].国际内分泌代谢杂志,2015,(03):183.[doi:10.3760/cma.j.issn.1673-4157.2015.03.011]
Liu Meijuan,Zhu Huijuan,Gong Fengying..Glypican-4 and obesity，insulin resistance[J].International Journal of Endocrinology and Metabolism,2015,(03):183.[doi:10.3760/cma.j.issn.1673-4157.2015.03.011]
[6]刘乐,于会宁,郭晓坤,等.OGTT 0.5 h血糖切点值在诊断糖尿病及糖尿病前期中的临床意义[J].国际内分泌代谢杂志,2015,(04):217.[doi:10.3760/cma.j.issn.1673-4157.2015.04.001]
Liu Le*,Yu Huining,Guo Xiaokun,et al.Clinical value of 0.5 h-plasma glucose and its cutoff value during OGTT in diagnosing diabetes mellitus and prediabetes[J].International Journal of Endocrinology and Metabolism,2015,(03):217.[doi:10.3760/cma.j.issn.1673-4157.2015.04.001]
[7]安丽,王秋月.Visfatin与胰岛素抵抗及糖尿病肾病的发病机制[J].国际内分泌代谢杂志,2015,(04):248.[doi:10.3760/cma.j.issn.1673-4157.2015.04.009]
An Li,Wang Qiuyue..Visfatin in the pathogenesis of insulin resistance and diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(03):248.[doi:10.3760/cma.j.issn.1673-4157.2015.04.009]
[8]冯静,魏亚聪,宋光耀.成纤维细胞生长因子21与胰岛素抵抗[J].国际内分泌代谢杂志,2015,(04):268.[doi:10.3760/cma.j.issn.1673-4157.2015.04.015]
Feng Jing*,Wei Yacong,Song Guangyao..Fibroblast growth factor 21 and insulin resistance[J].International Journal of Endocrinology and Metabolism,2015,(03):268.[doi:10.3760/cma.j.issn.1673-4157.2015.04.015]
[9]臧莎莎,朱亚军,宋光耀.Lipin与糖脂代谢[J].国际内分泌代谢杂志,2014,(01):22.[doi:10.3760/cma.j.issn.1673-4157.2014.01.006]
Zang Shasha*,Zhu Yajun,Song Guangyao.Lipin and glucolipid metabolism[J].International Journal of Endocrinology and Metabolism,2014,(03):22.[doi:10.3760/cma.j.issn.1673-4157.2014.01.006]
[10]王登,贾正平,李茂星,等.糖皮质激素与2型糖尿病[J].国际内分泌代谢杂志,2014,(02):118.[doi:10.3760/cma.j.issn.1673-4157.2014.02.014]
Wang Deng*,Jia Zhengping,Li Maoxing,et al.Glucocorticoid and type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2014,(03):118.[doi:10.3760/cma.j.issn.1673-4157.2014.02.014]